125 related articles for article (PubMed ID: 7438514)
1. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
Somerma S
Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
[No Abstract] [Full Text] [Related]
2. Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
Crijns MB; Nater JP; van Oostveen F; van der Valk PG
Contact Dermatitis; 1984 Aug; 11(2):108-11. PubMed ID: 6488765
[TBL] [Abstract][Full Text] [Related]
3. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
Reckers R; Wendt H
Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
[TBL] [Abstract][Full Text] [Related]
4. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
Seidenari S; Di Nardo A; Mantovani L; Giannetti A
Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
[TBL] [Abstract][Full Text] [Related]
5. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of anthralin inflammation. 2. Effect of pretreatment with glucocorticoids, anthralin and removal of stratum corneum.
Lawrence CM; Shuster S
Br J Dermatol; 1985 Jul; 113(1):117-22. PubMed ID: 4015968
[TBL] [Abstract][Full Text] [Related]
7. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter.
Queille-Roussel C; Poncet M; Schaefer H
Br J Dermatol; 1991 Mar; 124(3):264-70. PubMed ID: 2018732
[TBL] [Abstract][Full Text] [Related]
8. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
[TBL] [Abstract][Full Text] [Related]
9. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
Schmied C; Saurat JH
Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230
[TBL] [Abstract][Full Text] [Related]
10. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
Marks R
Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
[TBL] [Abstract][Full Text] [Related]
11. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
[TBL] [Abstract][Full Text] [Related]
12. Local tolerability of topically applied methylprednisolone aceponate.
Kecskés A; Jahn P; Lange L
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):786-8. PubMed ID: 8496430
[No Abstract] [Full Text] [Related]
13. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity.
Marks R; Sawyer M
Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
Woodford R
Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
[No Abstract] [Full Text] [Related]
15. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
Priestley GC
Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
[TBL] [Abstract][Full Text] [Related]
16. Steroid-induced vasoconstriction: glucocorticoid antagonist studies.
Marks R; Barlow JW; Funder JW
J Clin Endocrinol Metab; 1982 May; 54(5):1075-7. PubMed ID: 7061698
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
Rampini E; Rastelli A; Cardo P
Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
[TBL] [Abstract][Full Text] [Related]
18. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
[TBL] [Abstract][Full Text] [Related]
19. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study.
Andersen P; Milioni K; Maibach H
Br J Dermatol; 1993 Jun; 128(6):660-5. PubMed ID: 8338750
[TBL] [Abstract][Full Text] [Related]
20. The Duhring chamber assay for corticosteroid atrophy.
Frosch PJ; Behrenbeck EM; Frosch K; Macher E
Br J Dermatol; 1981 Jan; 104(1):57-65. PubMed ID: 7459270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
